CS alumnus David Sontag (B.A. ’05), now an assistant professor of EECS at MIT, has been appointed to the Strategic Advisory Board of GNS Healthcare, one of the world’s leading precision medicine companies. Sontag is also the Hermann L.F. von Helmholtz Career Development Professor in the Institute for Medical Engineering and Science (IMES), and principal investigator in the Computer Science and Artificial Intelligence Laboratory (CSAIL) at MIT. “GNS Healthcare’s approach is at the forefront of machine learning, working to truly unlock the full potential of patient data to determine the best available therapy and treatment options. I look forward to working closely with the GNS team and the Strategic Advisory Board,” said Sontag.